Rewrite her thrilling life Novel

The Billionaire's Last Obsession series 185 Summary At eight in the morning, Lillian, Karina, and others arrived at the Skyreach Pharmaceuticals factory for a significant product launch. Inside the lab, Candy and her team admired Lillian's fascination with modern pharmaceutical science, despite her background in traditional alchemy. The team held Lillian in high regard, appreciating the rare herbs provided by their young chairman, which were central to their innovative medicines.

Karina informed Lillian that the launch was about to begin, but Lillian chose to watch the event remotely from the lab. Karina confidently took charge of hosting the press conference, warmly addressing the gathered reporters. She explained the company's rapid growth in just three years and the chairman's decision to hold the launch at the factory to foster public understanding of their groundbreaking work. The head of research presented the new Light Pill, a medicine made entirely from rare herbs without chemical additives, impressing the audience with its miraculous effects.

When questioned, Karina clarified that the pill would not be mass-produced due to the rarity of its ingredients, making availability limited and exclusive. She also addressed inquiries about the chairman's absence from public events and the company's upcoming venture into the jewelry industry. After the presentation, the reporters toured the factory, witnessing the advanced cultivation of herbs, automated production workshops, and luxurious staff accommodations. The scale and sophistication of the operation amazed everyone, both on-site and watching the live broadcast.

The success of Skyreach Pharmaceuticals in under three years left the world, including the Sinclair family, stunned by the company's extraordinary achievements. Continue Regular Chapter Reading Below Chapter 185: The Product Launch At precisely eight o'clock in the morning, Lillian, Karina, and a handful of others arrived at the sprawling factory complex. The crisp air was filled with a sense of anticipation as the day's significant event was about to unfold. Inside the laboratory, Candy and her team watched Lillian with a mixture of admiration and curiosity.

Lillian was engrossed in studying various chemical formulations, her eyes reflecting a deep fascination. Having always relied on the ancient art of alchemy-using a cauldron to refine medicine-she was not well-versed in the intricacies of modern pharmaceutical science. This unfamiliar territory only heightened her interest, making her eager to absorb every detail of the cutting-edge research taking place around her. Despite this gap in experience, Candy and her colleagues held Lillian in the highest regard.

Since joining Skyreach Pharmaceuticals, they had been continually impressed by the company's medicinal gardens. The rare herbs cultivated there were nothing short of extraordinary. Each individual seedling could fetch an exorbitant price on the market, yet Skyreach treated these precious plants almost casually, blending them liberally into their medicinal products. All of these exceptional herbs were supplied by their young chairman, who also provided the cultivation techniques, dosage guidelines, and the state-of-the-art equipment used in the laboratory.

Every request for research support was promptly fulfilled, leaving the scientists feeling incredibly privileged to be part of such an innovative and well-supported institution. Karina stepped quietly into the lab and leaned in to speak softly to Lillian. "The launch is about to begin," she informed her. Still holding a test tube filled with a pale liquid, Lillian shook her head gently. "You go ahead and host it, Karina. I won't be attending in person. Every building is broadcasting live anyway-I'll watch it from here." Karina nodded with a confident smile.

"Alright, I'll take care of it." Having managed the factory for years, she was more than capable of handling the event on her own. At the press conference, the room was already buzzing with reporters as Karina stepped gracefully onto the stage. Her warm smile immediately put the audience at ease. "Good morning, everyone," she began. "I'm Karina, the general manager of Skyreach Pharmaceuticals. Thank you all for carving out time from your busy schedules to join us today." She paused briefly, letting her words settle.

"Skyreach Pharmaceuticals was founded just three years ago, and we've come this far thanks to your continued support and trust. Some of you may wonder why we chose to hold this launch here, at the factory itself. That decision was made by our chairman, who believes that the public deserves a deeper understanding of our group." "True appreciation comes from understanding," she continued. "Only then can people see why our medicines deliver such remarkable results.

Shortly, I will be guiding you on a tour of our facilities." "But first," she added, "our head of research will demonstrate and explain the effects of the Light Pill." For the next thirty minutes, the research director took the stage, presenting detailed data and conducting demonstrations. The reporters, many of whom didn't fully grasp the scientific jargon, were nonetheless left speechless by the sight of the glowing pale blue liquid. It was nothing short of miraculous. As soon as the presentation wrapped up, questions flooded in. "Ms. Karina, does the Light Pill have any side effects?

We all know that the more powerful a medicine is, the greater the potential risks," one reporter asked. Karina replied calmly, "No, it does not. All the ingredients are derived from herbs. We do not use any chemical additives, so there are no side effects." Another voice called out, "With such astonishing results, will Skyreach Group mass-produce the Light Pill?" Her smile remained steady. "The Light Pill will not be mass-produced. The herbs required are extremely rare and difficult to cultivate. Large-scale production is simply impossible.

Availability will be limited, and orders must be placed in advance." The word "limited" sent a ripple of surprise through the audience. Limited edition handbags and cars were common terms, but limited medicine? That was unprecedented. Still, given the pill's extraordinary effects, the explanation made sense. "Ms. Karina, why has the chairman of Skyreach Group never appeared at any events?" another reporter inquired. "Our chairman is fully dedicated to research and development," Karina responded with a composed smile.

"We, the team, handle public matters." A further question came, "We've heard that Skyreach Group is entering the jewelry industry. Is that true?" "That is correct," Karina confirmed. "However, the details of Skyreach Jewelry's creation remain confidential for now. Thank you for understanding." Questions kept coming, but Karina answered each one with grace and poise. Having faced dozens, if not hundreds, of interviews since Skyreach's inception, she was a seasoned professional. An hour later, the formal launch concluded, and the factory tour began.

Though the reporters had been impressed upon arrival, the deeper they ventured into the facility, the more awe-inspiring it became. In the research buildings, staff operated machines with flawless precision. The cultivation halls maintained perfect temperature control, nurturing rare herbs that grew in meticulously arranged tiers. It was no wonder Skyreach's medicines were so potent. The production workshops were fully automated, with strict sterilization protocols required for entry. Even the staff dormitories were furnished to a standard rivaling luxury hotels.

While the reporters could only observe from outside the restricted areas, they were visibly overwhelmed by the scale and sophistication of the operation. Meanwhile, the event was being broadcast live across multiple outlets, and viewers at home shared the same amazement at the vast capabilities of Skyreach Pharmaceuticals. No one could have predicted that in less than three years, this company would ascend to such remarkable heights. The entire world was stunned-especially the Sinclair family back in Kingston.

Conclusion The chapter closes on a note of quiet triumph and deep dedication, capturing the essence of Skyreach Pharmaceuticals' extraordinary journey. Lillian's fascination with the intricate blend of ancient alchemy and modern science embodies the spirit of innovation and perseverance that drives the company forward. Karina's poised leadership during the launch highlights the strength of teamwork and the unyielding commitment behind the scenes, revealing a shared passion that fuels their success.

The delicate balance between innovation and secrecy will be tested, potentially unveiling hidden tensions within the company or from external forces eager to capitalize on this miracle medicine. Emotionally, the spotlight on Karina's poised management and Lillian's quiet dedication sets the stage for more intimate revelations. As the public gaze intensifies, the personal sacrifices and inner struggles of these key characters may come to light, challenging their resolve and alliances.

The Sinclair family's reaction, hinted at but not yet explored, could introduce a new layer of conflict or intrigue, weaving personal stakes into the unfolding corporate drama. Readers will be drawn to see how ambition, loyalty, and ambition collide in the chapters ahead. Cedella Cedella is a passionate storyteller known for her bold romantic and spicy novels that keep readers hooked from the very first chapter. With a flair for crafting emotionally intense plots and unforgettable characters, she blends love, desire, and drama into every story she writes.

Cedella's storytelling style is immersive and addictive-perfect for fans of heated romances and heart-pounding twists.